Addressing the innovation gap.
The 10 years since the mid-1990s have witnessed an unprecedented investment in Drug Discovery driven by both the unraveling of the human genome and the parallel introduction of various high-throughput technologies. During the same period, industry metrics describe a decline in the numbers of new molecular entities launched upon the global pharmaceutical markets. The Society for Medicines Research (SMR) meeting entitled "Addressing the Innovation Gap" brought together a program of expert speakers to comment upon the challenges currently facing the pharmaceutical industry and some of the measures being undertaken to enable future success.
Jeffrey
Phillip
P
Society for Medicines Research (SMR) Committee, Thurmaston, Leicester, UK. secretariat@smr.org.uk
Warne
Peter
P
Williams
Robert
R
D004059:Diffusion of Innovation; D000939:Epitopes; D048088:Informatics; D010600:Pharmacology / Q000639:trends*
D000939:Epitopes